Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward

Overview of attention for article published in Alzheimer's & Dementia: the Journal of the Alzheimer's Association, January 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)

Mentioned by

twitter: 4 X users
facebook: 1 Facebook page

podcasts: 1 podcast

Readers on

mendeley: 203 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 4,705 followers.

Open Access UCL Research: Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward https://t.co/SmaRXEstRm

Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward. https://t.co/kJa3GA8bjg

New article: Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward. https://t.co/aFBPhy9DOZ #alzheimers #neurology

Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward. Alzheimers Dement #Alzheimers https://t.co/tjrs6dJi56

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.